Research Brief: VILIP-1 a Potential CSF Marker for AD?
Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098 Alzheimer's
373 RESULTS
You searched Esther AND Landhuis
Sort By:
Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098 Alzheimer's
that involve defective protein turnover, not just AD, “the payoff could be huge,” he said.—Esther Landhuis None
in their native context,” he told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3086
to promote linker cell death.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3076 Triplet
treatment.” (See full comment below.)—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3070
conference story) and in people with AD or mild cognitive impairment (see ARF related news story).—Esther
wrote.—Esther Landhuis. This is Part 1 of a two-part story. See Part 2. None
to develop AD therapeutic compounds that promote Aβ clearance without actually entering the brain.—Esther
is ApoE, which was reported 15 years ago.”—Esther Landhuis None
the original charge,” Montine said, noting they will not specify a protocol for clinicians.—Esther Landhuis
sophisticated screens that could deliver a more accurate diagnosis (see ARF related news story).—Esther Landhuis
Thompson said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3031 Alzheimer's Disease
premature aging.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3023 Aging Research Models
et al., 2009). ADsig has not been compared with functional MRI measures.—Esther Landhuis None
may be too damaged. “The wires might be frayed,” Eldaief said.—Esther Landhuis None